Documents

in page functions
 

01 November 2007

Evaluation of the first five years of GAVI Immunisation Services Support funding: follow-up on recommendations

Formal response by the GAVI Senior Management team for the GAVI Alliance Board to the recommendations of the 'Evaluation of the first five years of GAVI Immunisation Services Support funding'.

01 September 2007

Evaluation of the first five years of GAVI Immunisation Services Support funding

As GAVI enters its second phase, it is interested in evaluating whether ISS funding continues to further GAVI's objectives, and how best to maximise any positive impact. The Request for Proposal (RFP) issued by GAVI indicated three specific objectives: to assess the experience of the ISS scheme in Phase 1 (2000-2005); to assess the application [implementation] of ISS funding at country level and its relation to overall immunisation financing; to identify the relationship between the allocation of ISS funding and immunisation coverage rates (DTP3)

29 June 2007

Independent Expert Committee Recommendation for AMC Pilot

The Independent Expert Committee was convened to assess which of the six vaccines included in the Tremonti report would be most suitable for the pilot AMC.

11 March 2007

EEG Donor response

In May 2007, the AMC Donor Committee constituted an independent Economic Expert Group (EEG) to advise on the initial AMC design. This document is the donors' response to the EEG report.

09 February 2007

IFPMA Press Release in support of AMC Launch

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) welcomes the public commitment made by the governments of Canada, Italy, Norway and the United Kingdom to fund the pilot Advance Market Commitment (AMC) to stimulate the development of new pneumococcal vaccines for the poorest countries.

09 February 2007

Remarks by Her Majesty Queen Rania of Jordan on the AMC Launch 2007

Remarks of Her Majesty Queen Rania Al-Abdullah on the announcement of Advanced Market Commitments of $1.5 billion in Rome, Italy on 9 February 2007.

09 February 2007

Bill and Melinda Gates Foundation - Statement of Support

Statement from the Bill and Melinda Gates foundation announcing support for the pneumococcal AMC.

09 February 2007

Pope Address at Vaccine Project Launch

The address Pope Benedict XVI gave to the representatives of the Advance Market Commitment in Rome, Italy on 9 February 2007.

08 February 2007

Pneumococcal Disease - The Human Face

Stories of three young children in Africa and Asia and their fight against pneumococcal disease.

08 February 2007

Pneumococcal Disease Background

Streptococcus pneumoniae are bacteria that are frequently found in the upper respiratory tract of healthy children and adults. These bacteria, however, can also cause a range of infections – from relatively mild ear infections to fatal pneumonia, meningitis, and sepsis. Serious pneumococcal infections can occur throughout life, but children under two years old and the elderly are at highest risk. 

01 February 2007

An evaluation of GAVI Alliance efforts to introduce new vaccines via the Accelerated Development and Introduction Plans and the Hib Initiative

The Terms of Reference of the study are: to take stock of the way the environment for new vaccine development and introduction has evolved over the past four years; to assess the progress made and highlight the lessons learnt through the innovative ADIPs approach, the Hib initiative and other new vaccine introduction related GAVI supported activities; and, to make recommendations to the GAVI Board on the structure and finance [of] its continued support in this priority area in the coming years.

09 November 2006

Second Donor Working Group - Framework

Framework document for the pilot AMC for pneumococcal vaccines.

09 November 2006

Second Donor Working Group - Participants London, November 2006

List of participants at the 2nd meeting of the AMC working group.

09 November 2006

Second Donor Working Group - Agenda London, November 2006

Agenda of the second meeting of the Technical Working Group in London on 9 November 2006.

09 November 2006

Second Donor Working Group - Summary London, November 2006

Summary of the second meeting of the Technical Working Group on AMC held in London on 9 November 2006.

07 September 2006

First Donor Working Group - Summary Rome, 7 September 2006

Summary of the first meeting of the Technical Working Group on AMC held in Rome on 7 September 2006.

07 September 2006

Pilot Proposal

Pilot proposal for the Advance Market Committment to demonstrate both the feasability of the AMC mechanism and its impact on accelerating vaccine development, production scale-up and introduction.

28 February 2006

Independent Expert Committee Membership

List of members of the Indepedent Expert Committee meeting in Paris, France held the 27-28 February 2008.

02 December 2005

Tremonti Report to the G8 Finance Ministers

Background papers to the AMC providing the analysis underpinning Minister Giulio Tremonti's Report to the G8 Finance Ministers Advanced Market Commitments to Vaccines.

11 March 2005

Making markets for vaccines: Ideas to action

This report discusses the need to invest more in vaccines and the proposal of making a commitment in advance to buy vaccines if and when they are developed to create incentives for industry to increase investment in research and development.

 



close icon

modal window here